NCT05408416View on ClinicalTrials.gov

Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

May 29, 2022

Study Completion Date

May 29, 2022

Conditions
Proliferative Diabetic Retinopathy
Interventions
PROCEDURE

preoperative group and intraoperative group

ranibizumab injection (0.5mg/0.05ml) 3-5 days before vitrectomy or ranibizumab injection (0.5mg/0.05ml) at the end of vitrectomy

Trial Locations (1)

100044

People's Hospital of Peking University, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT05408416 - Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR | Biotech Hunter | Biotech Hunter